Mark W. FleckÂ
Associate Professor & CNN Director of Graduate Stu
Neuroscience and Experimental Therapeutics
Albany Medical College
United States of America
Biography
Dr. Mark W. Fleck is currently working as a Associate Professor & CNN Director of Graduate Studies in the Department of Neuroscience and Experimental Therapeutics, Albany Medical College , USA. His research interests includes pharmacology of receptors, factors influence subunit expression in neurons, synaptic transmission. He is serving as an editorial member and reviewer of several international reputed journals. Dr. Mark W. Fleck is the member of many international affiliations. He has successfully completed his Administrative responsibilities. He has authored of many research articles/books related to pharmacology of receptors, factors influence subunit expression in neurons, synaptic transmission.
Research Interest
pharmacology of receptors, factors influence subunit expression in neurons, synaptic transmission
Publications
-
Fleck MW (2002) Molecular actions of (S)-desmethylzopiclone (SEP-174559), an anxiolytic metabolite of zopiclone. J Pharmacol Exp Ther, 302(2):612-8
-
Fleck MW, Cornell E, Mah SJ (2003) Amino-acid residues involved in glutamate receptor 6 kainate receptor gating and desensitization. J Neurosci, 23(4):1219-27.
-
Kuehne ME, He L, Jokiel PA, Pace CJ, Fleck MW, Maisonneuve IM, Glick SD, Bidlack JM (2003) Synthesis and biological evaluation of 18-methoxycoronaridine congeners. Potential antiaddiction agents. J Med Chem, 46(13):2716-30.
-
Pace CJ, Glick SD, Maisonneuve IM, He LW, Jokiel PA, Kuehne ME, Fleck MW (2004) Novel iboga alkaloid congeners block nicotinic receptors and reduce drug self-administration. Eur J Pharmacol, 492(2-3):159-67.
-
Mah SJ, Cornell E, Mitchell NA, Fleck MW (2005) Glutamate receptor trafficking: ER quality control involves ligand binding and receptor function. J Neurosci, 25(9):2215-25.
